Clinical trials
Phase 3 Pathologic Processes trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 4 |
| 2020 | 3 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Active, not recruiting | 7 |
| Recruiting | 4 |
| Terminated | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bausch Health Americas, Inc. | 3 |
| Taysha Gene Therapies, Inc. | 2 |
| University of Colorado, Denver | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| Zealand Pharma | 2 |
| AO GENERIUM | 1 |
| AstraZeneca | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Consorcio Centro de Investigación Biomédica en Red (CIBER) | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Processes | 30 |
| Digestive System Diseases | 10 |
| Intestinal Diseases | 7 |
| Lung Diseases | 7 |
| Respiratory Tract Diseases | 7 |
| Gastrointestinal Diseases | 6 |
| Colonic Diseases | 5 |
| Genetic Diseases, Inborn | 5 |
| Nervous System Diseases | 5 |
| Colitis | 4 |
Trials
Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.